|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS. |
 |
| |
|
|
|
| Tim Sandle at Bio Products Laboratory investigates the innovative design and possibilities offered by data collection of active air-samplers, in A Breath of Fresh Air |
|
|
| In Leaning The Right Way, Daniel Nash at MAS argues that the pharmaceutical industry as a whole can minimise waste and operate more efficiently, thanks to lean manufacturing |
|
|
| The Ever-Changing Waste Landscape puts increasing pressure on pharmaceutical companies to initiate waste disposal and recycling strategies and accept their resposibilities, concludes Clare Noble of PHS |
|
|
| Harmonising IT with the actual operation of a company can reap significant competitive benefits in the marketplace.Wassermann AG’s Frank Altrichter and Joachim Schulte investigate, in The IT Crowd |
|
|
| In Making Gas a Quality Issue, Lieve de Paepe at Air Products claims that the legislation regarding emissions control results in a need for comprehensive compliance |
|
|
|
|
| Reconstitution devices are continuing to develop, and their usability for end-users should be a primary concern, explains Kevin Maynard at Imprint Pharmaceuticals Ltd, in The Therapeutics of Injections |
|
|
| Shaun Bainbridge of CSMA analyses the vital role of surface analysis in the use of drug delivering stent coatings, in Stents – Scratching the Surface |
|
|
|
| Erich R Brocker at Swiss Caps AG analyses the developments in the manufacture of soft capsules. Achieving Equilibrium, he finds, is critical to the problem of excess humidity |
|
|
|
|
| Finding Your Voice, by Vocollect Europe’s Greg Tanner, measures the impact of voice systems on the whole supply chain, and their competitive potential in the transforming pharmaceutical industry |
|
|
| Hans-Erik Gording at Bang & Olufsen Medicom argues that Intuitive Packaging can have a notable impact on patient adherence to long-term medication |
|
|
|
| Agility Ability is what distinguishes the most successful organisations, explains Carl Dugdale at George Group Consulting. Adapting to rapid change enables a company to prosper despite stiff competition |
|
|
| A combined use of direct torque control and the standard AC drive can achieve astounding results at a low cost. Steve Ruddell at ABB asks whether AC drives are Driving Servo-Drives Out? |
|
|
| Geraint Thomas of Laminar Medica appraises the potential of new temperature-sensitive packaging solutions to improve efficiency, cost and safety, in Cold Chain Control |
|
|
| The Perilous Road To Market can have catastrophic implications for your products, purports Andy Hughes at Pharmafreight Ltd. Crucial procedures can be implemented to avoid the risks |
|
|
| Two dimensional symbology continues to maintain its significance amongst evolving identification technology. New Dimensions in Supply Chain Security, by Dan Bodnar at Intermec, outlines the benefits of this cheaper alternative to RFID |
|
|
| Mike McMillan at QinetiQ observes that the information within RFID tags must be accessed throughout the supply chain and manufacturing process in order to maximise their potential, in Following the Tracks |
|
|
| Bringing Europe Up to Speed has long been considered imperative for the pharmaceutical industry, and adopting RFID is the optimum solution, claims Rob McGregor at TOSHIBA TEC Europe |
|
|
|
| Producing and distributing ultrapure water is The Challenge of Biotechnology, asserts Helmut Sommer of Christ Water Technology Group. Purified water is used increasingly throughout biotechnology |
|
|
| Pure Water for Clear Results is the formula for effective processing in the pharmaceutical manufacturing industry, especially when appropriately processed and treated, writes Mark Bosley of Purite |
|
|
|
| Automatic Art, by Neil Gleghorn at Kallik, outlines the necessary steps and advantages of automating the production of label artwork. He anticipates data management solutions configured to store artwork data in the near future |
|
|
| Whilst RFID is now a reputable security measure, Seeing is Believing, advises Nicole Golomb at Secutag. Alternative anti-counterfeit options are becoming increasingly esteemed, alongside RFID |
|
|
| Peter Harrop at IDTechEx portends that, despite higher costs, RFID will surpass DataMatrixTM among security measures for more sophisticated Advanced Packaging |
|
|
|
| Drug Packaging – The Prescription for Success expounds the fundamental role that packaging can play in the fight for patient compliance, particularly in long term medical regimens. Tassilo Korab at Healthcare Compliance Packaging Council also gives us a taste of the upcoming 2007 conference |
|
|
| The multiple technical solutions for encapsulating liquids can improve product quality whilst streamlining the process itself. Liquid-filled capsules are proving their worth as an alternative to hard capsule filling. Felix Nink at Robert Bosch GmbH Packaging Technologies assesses the latest Production Values |
|
|
| As solutions to the crisis of low patient compliance continue to emerge, Thomas Grinnan of MeadWestvaco wonders how packaging may evolve, in Prescriptive Drugs? |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics
Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in
the research and manufacture of advanced technologies for the separation
sciences, introduces bioZen – a new series of LC solutions for bioseparations
in pharmaceutical, biopharmaceutical and academic research. The series
encompasses both proven and entirely new media spanning two particle platforms
– core-shell and thermally modified fully porous – along with new biocompatible
titanium hardware. The initial bioZen product line features seven chemistries
for the UHPLC and HPLC characterization of biotherapeutics such as monoclonal
antibodies, antibody-drug conjugates and biosimilars. The offering includes
specific LC chemistries for the analysis of aggregates and total mAb, intact
mass and fragments, peptide mapping and quantitation and glycan mapping.
More info >> |
|
 |
White Papers |
 |
|
Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences
CIDP (Centre International de Développement Pharmaceutique)
Mauritius, the tropical island situated in the Indian Ocean and known
worldwide for its beautiful beaches, is also internationally recognised
for its rule of law, and political and social stability. Over the past
few years, the economy has been successfully transitioned from a
monocrop to a diversified innovation-driven and knowledge-based economy,
resting on agribusiness, export-oriented manufacturing, tourism,
financial services, property development and real estate, ICT-BPO, the
seafood industry, a free port, logistics and a nascent ocean economy.
Emerging sectors such as healthcare and life sciences are presenting
some niche areas for the taking, and the enabling environment is being
put in place to make it happen - especially in the light of sustained
growth within pharmaceutical, medical device, and clinical research.
Important
international players are already in operation locally as the country
has established the appropriate legal and regulatory frameworks based on
international norms, for the development of a strong biomedical
research sector.
More info >> |
|
 |
Industry Events |
 |
SMI Immuno-Oncology Conference
25-27 September 2018, Copthorne Tara Hotel, London, UK
Immuno-Oncology is a fast-paced field with massive potential to deliver
successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of
the field with a representation of the whole industry under each area. These
areas will be drawn together to look towards the future of Immuno-oncology and
how the field can progress.
More info >> |
|
|
